Newsroom | 83773 results

TÓQUIO--(BUSINESS WIRE)--A Rigaku Corporation, uma empresa do Grupo Rigaku Holdings Corporation (sede: Akishima, Tóquio; CEO: Jun Kawakami; denominada aqui “Rigaku”), e a SPERA PHARMA, Inc. (sede: Osaka; presidente e diretor representante: Keitaro Iwaki; denominada aqui “SPERA PHARMA”) iniciaram uma parceria estratégica com o objetivo de acelerar e transformar o desenvolvimento farmacêutico, aproveitando as tecnologias de ponta e a ampla experiência das duas empresas. A SPERA PHARMA usará o Xta...

TOKYO--(BUSINESS WIRE)--Rigaku Corporation, société du groupe Rigaku Holdings Corporation (siège : Akishima, Tokyo ; président-directeur général : Jun Kawakami, ci-après « Rigaku »), et SPERA PHARMA, Inc. (siège : Osaka ; président-directeur général : Keitaro Iwaki, ci-après « SPERA PHARMA ») ont conclu un partenariat stratégique visant à accélérer et transformer le développement pharmaceutique, en s’appuyant sur des technologies de pointe et sur l’expertise complémentaire des deux entreprises....

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity Life Sciences, the leader in strategy, insights and analytics for the life sciences industry, introduced its artificial intelligence (AI) algorithm which accurately predicted revenue outcomes for over 90% of U.S. drug launches, far exceeding the accuracy of Wall Street analyst consensus at the time of launch (<60%). Trinity’s latest white paper in its Industry Impact Series, titled Predicting Winners: AI-Powered Portfolio Management, explores the use...

LOS ANGELES--(BUSINESS WIRE)--Researchers with City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S. with its National Medical Center named top 5 in the nation for cancer by U.S. News & World Report, will present the latest cancer research at the AACR Annual Meeting 2025, which will take place April 25 to 30 in Chicago. City of Hope experts will present more than 74 chaired, plenary, educational, minisymposium, poster and other sessions...

TOKYO--(BUSINESS WIRE)--Rigaku Corporation, a Group company of Rigaku Holdings Corporation (headquarters: Akishima, Tokyo; CEO: Jun Kawakami; hereinafter “Rigaku”), and SPERA PHARMA, Inc. (headquarters: Osaka; President & Representative Director: Keitaro Iwaki; hereinafter “SPERA PHARMA”) have initiated a strategic partnership aimed at accelerating and transforming pharmaceutical development by leveraging the two companies’ cutting-edge technologies and extensive expertise. SPERA PHARMA wil...

DUBLIN--(BUSINESS WIRE)--The "Morphine Hydrochloride (CAS 52-26-6) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029" report has been added to ResearchAndMarkets.com's offering. This report on Morphine hydrochloride provides comprehensive insights, including general information, synonyms, chemical composition, safety, hazards, handling, storage, and toxicological and ecological details, along with transport information. This in-depth study serves as a vita...

DUBLIN--(BUSINESS WIRE)--The "Ketamine Hydrochloride (CAS 1867-66-9) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029" report has been added to ResearchAndMarkets.com's offering. This report on Ketamine hydrochloride provides comprehensive insights, including general information, synonyms, chemical composition, safety, hazards, handling, storage, and toxicological and ecological details, along with transport information. This in-depth study serves as a vi...

GOLDEN, Colo.--(BUSINESS WIRE)--PharmaJet to present partner data showing how needle-free can be expected to enhance vaccine immune response in difficult-to-treat cancer patients....

DUBLIN--(BUSINESS WIRE)--The "Fentanyl (CAS 437-38-7) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029" report has been added to ResearchAndMarkets.com's offering. This report on Fentanyl provides comprehensive insights, including general information, synonyms, chemical composition, safety, hazards, handling, storage, and toxicological and ecological details, along with transport information. This in-depth study serves as a vital resource for understandin...

DUBLIN--(BUSINESS WIRE)--The "Amlodipine (CAS 88150-42-9) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029" report has been added to ResearchAndMarkets.com's offering. This report on Amlodipine provides comprehensive insights, including general information, synonyms, chemical composition, safety, hazards, handling, storage, and toxicological and ecological details, along with transport information. This in-depth study serves as a vital resource for unders...